APTO: Aptose Biosciences Inc. Stock

by  •  • Comments Off on APTO: Aptose Biosciences Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 4.76
Enterprise Value ($M) 6.80
Book Value ($M) -2.18
Book Value / Share -0.11
Price / Book -2.19
NCAV ($M) -9.83
NCAV / Share -0.50
Price / NCAV -0.48

Profitability (mra)
Return on Invested Capital (ROIC) -4.19
Return on Assets (ROA) -1.71
Return on Equity (ROE) -4.60

Liquidity (mrq)
Quick Ratio 1.05
Current Ratio 1.05

Balance Sheet (mrq) ($M)
Current Assets 10.23
Assets 10.93
Liabilities 20.06
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
9 days ago 13G Armistice Capital, Llc 9.99
02-14 13G/A Nantahala Capital Management, LLC 1.50 -98.02
02-05 13D/A Hanmi Pharmaceutical Co., Ltd. 22.17 238.11

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 2,067,394 7,992,062 25.87
2024-11-21 183,430 488,865 37.52
2024-11-20 267,724 687,519 38.94
2024-11-19 153,196 289,280 52.96
2024-11-18 67,576 367,143 18.41

(click for more detail)

Similar Companies
ANIX – Anixa Biosciences, Inc. APM – Aptorum Group Limited
APRE – Aprea Therapeutics, Inc. APVO – Aptevo Therapeutics Inc.
ARTL – Artelo Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io